Adenosine A2A receptor antagonists for Parkinson’s disease: rationale, therapeutic potential and clinical experience. Drugs Aging. 2005;22:471-482.

Hauser, RA, and MA Schwarzchild. 2005. “Adenosine A2A Receptor Antagonists for Parkinson’s Disease: Rationale, Therapeutic Potential and Clinical Experience. Drugs Aging. 2005;22:471-482.”. Drugs Aging.

Last updated on 11/12/2024